BioSimilar FDA Approves Sixth United States Biosimilar Thomas Sullivan Nov 17, 2017 0 Recently, the FDA announced that it approved Boehringer Ingelheim’s Cyltezo (adalimumab-adbm), the second biosimilar to AbbVie’s…
